Elite in Membranous Nephropathy

Barbara Polski-Seitz

Nice, FR 
Elite in Membranous Nephropathy
Nice, FR 
OverviewLocationsClinical Research

Overview

Barbara Polski-Seitz practices in Nice, France. Ms. Polski-Seitz is rated as an Elite expert by MediFind in the treatment of Membranous Nephropathy. Her top areas of expertise are Membranous Nephropathy, Glomerulonephritis, Nephrotic Syndrome, Severe Acute Respiratory Syndrome (SARS), and Kidney Transplant.

Her clinical research consists of co-authoring 67 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 30 articles and participated in 1 clinical trial in the study of Membranous Nephropathy.

Gender
Female

Locations

Nice, France
Other Locations
Sophia Antipolis, France
Valbonne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Functional Non Specific Immunity Monitoring After Kidney Transplantation Using an Interferon Gamma Test, QuantiFERON Monitor®
Functional Non Specific Immunity Monitoring After Kidney Transplantation Using an Interferon Gamma Test, QuantiFERON Monitor®
Enrollment Status: Completed
Publish Date: August 01, 2024
Intervention Type: Other
Study Phase: Not Applicable
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Enrollment Status: Completed
Publish Date: February 06, 2024
Intervention Type: Other
Study Phase: Not Applicable
Indication and Response to Immunosuppressive Treatment in Membranous Nephropathy : Role of Anti-mouse PLA2R1 ELISA
Indication and Response to Immunosuppressive Treatment in Membranous Nephropathy : Role of Anti-mouse PLA2R1 ELISA
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Evaluation of Prevenar 13's Vaccine Response in Patients Hospitalized in Infectious Disease Department for Sepsis
Evaluation of Prevenar 13's Vaccine Response in Patients Hospitalized in Infectious Disease Department for Sepsis
Enrollment Status: Completed
Publish Date: August 03, 2023
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

67 Total Publications

Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial.
Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial.
Journal: BMJ open
Published: April 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Polski-Seitz's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile